Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
QuartzBio is an advanced platform focused on precision medicine that aims to revolutionize the operations of clinical development and translational research teams by creating a cohesive data environment. This environment allows for the integration, synchronization, exploration, and analysis of biospecimen, biomarker, and clinical data through the use of conversational AI technology. Its core offerings include the Precision Medicine AI Agent Platform, which encompasses vital tools such as Sample Intelligence, providing a comprehensive overview of the lifecycle of biospecimens from their collection to long-term storage, complemented by features like automated logistics, stability tracking, and data reconciliation. Furthermore, the platform boasts Biomarker Intelligence, which facilitates the seamless ingestion of assay data across various modalities, including DNA, RNA, protein, and cell-based formats, along with a no-code data-mapping feature, global search capabilities, interactive dashboards, visual analytics, and modules for genomic and cytometry data. To enhance user experience, the Agent Intelligence layer further allows stakeholders to perform natural-language queries, making data interaction more intuitive and efficient than ever before. This innovative approach not only streamlines workflows but also empowers research teams with enhanced insights for better decision-making.
Description
By leveraging visual analytics through TIBCO Spotfire®, PerkinElmer Signals Translational offers a comprehensive suite of tools designed to harmonize, manage, search, aggregate, and analyze extensive datasets consistently for translational research, all while ensuring scalability. This platform, driven by TIBCO Spotfire®, supports precision medicine initiatives by providing an unparalleled solution for biomarker discovery and patient stratification. The Linear Mixed Effect App (LME) within Signals Translational empowers researchers to evaluate the influence of various factors on specific phenotypes, allowing for adjustments related to random variables during analysis. Furthermore, it enables the identification of genes significantly affecting cancer stage progression, irrespective of patient origins. Notably, the LME models excel at addressing issues such as missing values and outliers, making them a robust choice for discovering potential biomarkers. Consequently, the integration of these advanced analytics tools enhances the efficacy of translational research in identifying key biomarkers that can lead to more personalized treatment approaches.
API Access
Has API
API Access
Has API
Integrations
Signals Research Suite
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
QuartzBio
Country
United States
Website
www.quartz.bio/
Vendor Details
Company Name
PerkinElmer
Founded
1937
Country
United States
Website
perkinelmerinformatics.com/products/clinical-translational/signals-translational/
Product Features
Scientific Data Management System (SDMS)
Analytics
Artificial Intelligence (AI)
Audit
Centralized Data Repository
Collaboration
Compliance
Data Security
ELN Integration
LIMS Integration
Workflows